You are here:
Company

PIMS-E

Back to overview

PIMS-E is a pharmaceutical company based in Roden with its own development and production facilities. PIMS-E was founded as a result of a collaboration between the departments of Pharmaceutical Technology and Biopharmacy at the University of Groningen by Professor Dr. H. W. Frijlink. This unique collaboration provides PIMS-E with an experienced, enthusiastic and highly motivated team of researchers, pharmacists, pharmacy assistants, pharmaceutical experts, QA/RA professionals and product process developers.

PIMS-E used inhalation technology to develop an alternative to the Epipen™, Cyclops® (dry-powder inhalation): which administers adrenaline to people experiencing a life-threatening allergic reaction to bee or wasp stings or to medicines or food. The substance takes effect almost instantly through  powder inhalation, has a long shelf-life (it does not need to be stored in the fridge) and there is no further need for injections.

PIMS-E belongs to the fund:

Carduso Capital B.V.">

Carduso Capital participates in technology companies that are preferably based on the know-how represented in and originating from the Groningen science cluster in and around the University of Groningen (RUG) and the ...

View all the funds from the IFG

NextGen Ventures 2 invests in knowledge-intensive data-driven companies that are changing healthcare – preferably ...
Berk Partners Groeifonds invests in existing, fast-growing Dutch SME companies, mainly in the following industries: inno...